Some breast cancer patients are having to pay tens of euros from their own pockets after the government ended its financial support.
They are having to pay for a powerful medicinal drug from their own money or forced to skip treatment altogether because they cannot afford it. NGOs have now alerted authorities to the lack of local access to the drug. They warn that those unable to afford the treatment are risking premature death.
Pembrolizumab is used to treat various cancers and are authorised for use by the European Medicines Agency and available on national health systems throughout the EU. Experts deem it as a breakthrough and a new hope to patients in the treatment of triple negative breast cancer.
Addressing cancers such as TNBC, one of the most aggressive forms of breast cancer, patients usually treated it through chemotherapy, surgery and radiotherapy. Pembrolizumab is the only treatment that reduces chances of recurrence by 40%.
One full course of it in line with EMA recommendations can cost up to €120,000, Times of Malta was informed. Patients remarked how neither the government nor the Malta Community Chest Fund foundation are financially supporting patients.
Government stopped financial support mid-2021, according to patients and two NGOs. Europa Donna Malta and Action for Breast Cancer Foundation wrote to the Health Ministry to voice their serious concern at the situation in October.
Malta remains an exception as the treatment is available on the national Public Health Service systems in all European countries. Times of Malta has attempted to reach the Health ministry in regards to this situation.
#MaltaDaily